The Female Health Company (FHC) reported that the company will present at the Drexel Hamilton Micro-Cap Investor Forum on Thursday, May 12, 2016 at 3:30 p.m. ET at Drexel Hamilton’s offices in New York City.
FHC recently announced a transformative merger agreement with Aspen Park Pharmaceuticals (APP). O.B. Parrish, CEO of FHC, and Mitch Steiner, M.D., CEO of APP, will present an overview of the transaction and provide highlights of the combined company.
The presentation will be available to interested parties through a live web broadcast with slides though the Internet at www.fhcinvestor.com. Listeners are encouraged to visit the website at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. The presentation will be archived and accessible on the website four business days after the conference.
Female Health Company
Aspen Park Pharmaceuticals